1. Home
  2. MLAB vs FISI Comparison

MLAB vs FISI Comparison

Compare MLAB & FISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLAB
  • FISI
  • Stock Information
  • Founded
  • MLAB 1982
  • FISI 1817
  • Country
  • MLAB United States
  • FISI United States
  • Employees
  • MLAB N/A
  • FISI N/A
  • Industry
  • MLAB Industrial Machinery/Components
  • FISI Major Banks
  • Sector
  • MLAB Industrials
  • FISI Finance
  • Exchange
  • MLAB Nasdaq
  • FISI Nasdaq
  • Market Cap
  • MLAB 524.2M
  • FISI 538.9M
  • IPO Year
  • MLAB N/A
  • FISI 1999
  • Fundamental
  • Price
  • MLAB $75.62
  • FISI $26.06
  • Analyst Decision
  • MLAB Hold
  • FISI Buy
  • Analyst Count
  • MLAB 2
  • FISI 3
  • Target Price
  • MLAB $130.00
  • FISI $33.00
  • AVG Volume (30 Days)
  • MLAB 180.8K
  • FISI 179.3K
  • Earning Date
  • MLAB 08-05-2025
  • FISI 07-24-2025
  • Dividend Yield
  • MLAB 0.85%
  • FISI 4.76%
  • EPS Growth
  • MLAB N/A
  • FISI N/A
  • EPS
  • MLAB N/A
  • FISI N/A
  • Revenue
  • MLAB $240,978,000.00
  • FISI $108,628,000.00
  • Revenue This Year
  • MLAB $6.45
  • FISI $122.14
  • Revenue Next Year
  • MLAB $5.80
  • FISI $5.87
  • P/E Ratio
  • MLAB N/A
  • FISI N/A
  • Revenue Growth
  • MLAB 11.47
  • FISI N/A
  • 52 Week Low
  • MLAB $67.95
  • FISI $20.97
  • 52 Week High
  • MLAB $155.12
  • FISI $29.79
  • Technical
  • Relative Strength Index (RSI)
  • MLAB 35.79
  • FISI 43.58
  • Support Level
  • MLAB $67.95
  • FISI $26.60
  • Resistance Level
  • MLAB $80.93
  • FISI $27.61
  • Average True Range (ATR)
  • MLAB 4.25
  • FISI 0.67
  • MACD
  • MLAB -0.44
  • FISI -0.14
  • Stochastic Oscillator
  • MLAB 28.05
  • FISI 19.02

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About FISI Financial Institutions Inc.

Financial Institutions Inc operates as a financial holding company, engages in the provision of a wide range of consumer and commercial banking services to individuals, municipalities, and businesses in Western and Central New York. It operates through one segment: The Banking segment which includes all of the company's retail and commercial banking operations.

Share on Social Networks: